Will L Goff

Title: Will L Goff: Innovator in Babesia Research

Introduction

Will L Goff is a notable inventor based in Moscow, ID (US), recognized for his contributions to the field of biotechnology. He holds 2 patents that focus on the identification and application of novel proteins related to Babesia bovis, a significant pathogen affecting livestock.

Latest Patents

Goff's latest patents include "Cloned Babesia DNA," which concerns the identification of novel merozoite surface proteins of Babesia bovis. This invention also discloses monoclonal antibodies to these proteins and the genes encoding them. Furthermore, it addresses the use of these novel proteins, recombinant DNA clones, and monoclonal antibodies in the detection, treatment, and prophylaxis of babesiosis. Another significant patent is "Cloning of the Babesia bovis 60 KD antigen," which shares similar themes and applications as the first, emphasizing the importance of these proteins in combating the disease.

Career Highlights

Throughout his career, Goff has worked with esteemed organizations such as the University of Florida Research Foundation and the United States of America as represented by the United States. His work has significantly advanced the understanding and treatment of babesiosis, showcasing his dedication to research and innovation.

Collaborations

Goff has collaborated with notable colleagues, including Terry F McElwain and Travis C McGuire, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Will L Goff's innovative work in the field of Babesia research has led to significant advancements in the detection and treatment of this disease. His contributions continue to influence the biotechnology landscape and improve animal health.